You can buy or sell PLX and other stocks, options, ETFs, and crypto commission-free!
Protalix Biotherapeutics, Inc. engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa and OPRX-106. Read More The company was by Yoseph Shaaltiel in 1993 and is headquartered in Karmiel, Israel.
52 Week High
52 Week Low
— per share
Expected May 4, Pre-Market